Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Treatment for Small Subarachnoid Hemorrhage (SAH)

Initial Management

  • The American Heart Association recommends rapid assessment of clinical severity using validated scales as it is the most useful indicator of outcome 3, 4
  • Urgent transfer to high-volume centers with experienced cerebrovascular surgeons, endovascular specialists, and multidisciplinary neurocritical care services is recommended, as outcomes are better at institutions that treat high volumes of SAH patients 3, 4
  • Blood pressure should be controlled with a titratable agent to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure 3

Specific Treatments

Aneurysm Management

  • The American Stroke Association recommends surgical clipping or endovascular coiling of the ruptured aneurysm should be performed as early as feasible to reduce the rate of rebleeding 3
  • For patients with ruptured aneurysms amenable to both endovascular coiling and neurosurgical clipping, endovascular coiling should be considered as the first option 3, 5
  • Complete obliteration of the aneurysm is recommended whenever possible 3

Prevention of Delayed Cerebral Ischemia (DCI)

  • Oral nimodipine should be administered at a dose of 60 mg every 4 hours for 21 consecutive days, starting within 96 hours of hemorrhage onset 1
  • Nimodipine has been shown to improve neurological outcomes but not cerebral vasospasm itself 2
  • Maintenance of euvolemia and normal circulating blood volume is recommended to prevent DCI 1, 2
  • Prophylactic hypervolemia and triple-H therapy are not recommended as they can increase complications 6, 7

Management of Hydrocephalus

  • Acute symptomatic hydrocephalus should be managed by cerebrospinal fluid diversion (external ventricular drainage or lumbar drainage, depending on the clinical scenario) 1, 2
  • Chronic symptomatic hydrocephalus should be treated with permanent cerebrospinal fluid diversion 2
  • Weaning external ventricular drainage over >24 hours does not appear to be effective in reducing the need for ventricular shunting 2

Seizure Management

  • Routine prophylactic anticonvulsants are not recommended for all patients with SAH 2
  • Patients treated with endovascular coiling have a lower incidence of seizures compared to those treated with surgical clipping 2

Monitoring and Follow-up

  • Cerebrovascular imaging after treatment and subsequent imaging monitoring are important to identify remnants, recurrence, or regrowth of the treated aneurysm 1
  • Transcranial Doppler ultrasonography can be used to monitor for vasospasm development 5
  • Early identification with validated screening tools can identify deficits, especially in behavioral and cognitive domains 1

Common Pitfalls and Considerations

  • Misdiagnosis is common in SAH, and high suspicion should be maintained with acute severe headache 3
  • Hypervolemia is potentially harmful and associated with excess morbidity; euvolemia should be the target 3, 6